ArticleJournal for immunotherapy of cancer2021

Extracellular HMGB1 blockade inhibits tumor growth through profoundly remodeling immune microenvironment and enhances checkpoint inhibitor-based immunotherapy.

Pascale Hubert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.